<DOC>
	<DOCNO>NCT01893840</DOCNO>
	<brief_summary>A study assess effect negative pulsating pressure therapy patient impaired blood flow leg cause arterial disease , see FlowOx device increase blood flow leg patient .</brief_summary>
	<brief_title>Effect Blood Flow Using FlowOxâ„¢ Device Patients With Reduced Peripheral Circulation Lower Leg</brief_title>
	<detailed_description />
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<criteria>Written Informed Consent Age 3090 year Affected foot/shoe sise le 46 ( approximate foot length le 29.5 cm ) Patients Peripheral Arterial Occlusive Disease ( PAOD ) grade 2,3 4 , i.e . : 1 . Clinically verified grade 2 , i.e . Intermittent Claudication : AncleBrachial Index ( ABI ) less 0.9 Toe brachial Index ( TBI ) less 0.7 Ultrasound and/or CT/Magnetic Resonance ( MR ) angiography suggest stenosis ( e ) and/or occlusion ( ) 2 . Clinically verified grade 3 , i.e . Critical Limb Ischemia ( CLI ) : ABI le 0.4 Toe pressure le 30 mmHg Rest pain since least 2 week Use analgesic rest pain least 2 week Ultrasound and/or CT/Magnetic Resonance ( MR ) angiography suggest stenosis ( e ) and/or occlusion ( ) 3 . Clinically verified grade 4 , i.e . CLI : Ischemic ulcer gangrene/tissue loss ABI le 0.4 Toe pressure le 30 mmHg Rest pain since least 2 week Use analgesic rest pain least 2 week Ultrasound and/or CT/MR angiography suggest stenosis ( e ) and/or occlusion ( ) Grade 1 PAOD Incapable consent voluntarily Fewer high 39 degree Centigrade Severe Chronic Obstructive Pulmonary Disease ( COPD ) Severe heart disease unstable angina , severe heart failure severe valve failure Severe Polyneurophathy Verified Osteomyelitis Phanlanx Currently treat cancer With life expectancy le 2 year</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>